[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT06919887":3,"trial-entities:NCT06919887":86,"trial-summary:NCT06919887":90},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":21,"study_type":22,"primary_purpose":23,"phases":24,"enrollment_info":26,"interventions":29,"primary_outcomes":40,"secondary_outcomes":51,"sex":52,"minimum_age":53,"maximum_age":54,"healthy_volunteers":15,"eligibility_criteria":55,"std_ages":66,"locations":69,"central_contacts":78,"overall_officials":79,"references":80,"see_also_links":85},"NCT06919887","24-013662","A Randomized Controlled Trial of Menopausal Tool\u002FApp for Women","Evaluation of a Mobile Phone Application Tool for Menopause Symptom Management","ENROLLING_BY_INVITATION","2027-12-15","2026-06","2026-06-16","2025-05-07","Mayo Clinic","OTHER",false,"The purpose of this study is about assessing the utilization of a mobile phone application (app), designed to improve the menopause experience of midlife women experiencing related symptoms and its association with menopause-related health care utilization",null,[19,20],"Menopausal Symptoms","Menopause Symptom Management",[],"INTERVENTIONAL","SUPPORTIVE_CARE",[25],"NA",{"count":27,"type":28},900,"ESTIMATED",[30,35],{"type":14,"name":31,"description":32,"armGroupLabels":33},"EMMII","The tool\u002Fapp, consists of educational components designed to enable women to more effectively identify menopause symptoms and feel confident in seeking treatment to address their symptoms. The tool\u002Fapp also produces a tailored menopause discussion guide for patients to bring to their primary care appointment.",[34],"The tool\u002Fapp, EMMII by BettrHealth",{"type":14,"name":36,"description":37,"armGroupLabels":38},"Comparison Group","Receive educational menopause pamphlet describing menopause symptoms and evidence-based treatment options.",[39],"Comparison Group\u002F Control Group",[41,44,46,49],{"measure":42,"timeFrame":43},"Frequency of app logins among intervention group.","Up to 6 weeks",{"measure":45,"timeFrame":43},"Compare differences in rates of menopause treatment among intervention and comparison groups.",{"measure":47,"timeFrame":48},"Mean score on a validated survey assessing perceived importance and availability of healthcare services for women's health conditions\u002Fconcerns related to menopause","through study completion, an average of 1 year",{"measure":50,"timeFrame":48},"Percentage of healthcare professionals reporting 'high' & 'low' confidence in diagnosing and managing menopause symptoms",[],"ALL","24 Years","80 Years",{"inclusion":56,"exclusion":62,"raw_text":65},[57,58,59,60,61],"Women between the ages of 45 and 55","English speaking (app only available in English)","Able to provide informed consent","Experiencing menopause symptoms, which will be assessed by a Menopause Rating Scale (MRS) survey score of ≥ 5","Has an upcoming Mayo Clinic primary care appointment within 3 weeks of the enrollment and the MRS survey",[63,64],"Lack of willingness to engage with app","Inability to provide informed consent","For Patient Enrollment:\n\nInclusion Criteria:\n\n* Women between the ages of 45 and 55\n* English speaking (app only available in English)\n* Able to provide informed consent\n* Experiencing menopause symptoms, which will be assessed by a Menopause Rating Scale (MRS) survey score of ≥ 5\n* Has an upcoming Mayo Clinic primary care appointment within 3 weeks of the enrollment and the MRS survey\n\nExclusion Criteria:\n\n* Lack of willingness to engage with app\n* Inability to provide informed consent",[67,68],"ADULT","OLDER_ADULT",[70],{"facility":13,"city":71,"state":72,"zip":73,"country":74,"geoPoint":75},"Rochester","Minnesota","55905","United States",{"lat":76,"lon":77},44.02163,-92.4699,[],[],[81],{"pmid":82,"type":83,"citation":84},"41061260","DERIVED","Karam J, Paul MM, Shufelt C, Ravikumar P, Fratianni AM, Oloyede S, Pagel EM, Hedges MS, Kapoor E, Kling JM, Cole K, Chaudhry R, Faubion SS. Evaluating the Efficacy of a Mobile Phone App in Enhancing Menopause Knowledge and Shared Decision-Making: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Oct 8;14:e76536. doi: 10.2196\u002F76536.",[],{"nct_id":4,"conditions":87,"biomarkers":89},[88],"Menopausal Symptom",[],{"nct_id":4,"found":15,"summary":17,"prompt_version":17}]